3439.60
4.17%
Karvy
Revenue growth on account of low base due to GST: Revenues for the quarter at Rs 7357 mn were above our estimates of Rs 6675mn on account of low base due to GST last year. The operatingmargins at 19.1% in Q1FY19 were in line with our estimates of 19%.
GlaxoSmithKline Pharmaceuticals Ltd. has gained 16.18% in the last 1 Month
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended